Citation Nr: 22017710 Decision Date: 03/25/22 Archive Date: 03/25/22 DOCKET NO. 17-55 915A DATE: March 25, 2022 ORDER Entitlement to an initial rating of 20 percent for lumbar degenerative arthritis with lumbosacral strain (lumbar spine disability), is granted. Entitlement to a rating in excess of 20 percent for lumbar spine disability is denied. Entitlement to a separate 10 percent rating for right lower extremity radiculopathy effective November 19, 2019, is granted. Entitlement to a separate 10 percent rating for left lower extremity radiculopathy effective November 19, 2019, is granted. Entitlement to a 20 percent rating for sensory impairment right lower extremity effective September 30, 2020, is granted. Entitlement to a 40 percent rating for sensory impairment right lower extremity effective September 30, 2020, is granted. Entitlement to an initial 60 percent rating for pilonidal cyst, is granted. FINDINGS OF FACT 1. Prior to August 18, 2021, the Veteran's lumbar spine disability manifested by limitation of forward flexion to 50 degrees considering the Veteran's pain and corresponding functional loss, including during flare-ups, her low back disability. 2. Throughout the appeal period, the Veteran's lumbar spine was manifested by no worse than forward flexion to 50 degrees. 3. Since November 19, 2019, the Veteran has had right lower extremity radiculopathy approximating mild incomplete paralysis of the sciatic nerve. 4. Since November 19, 2019, the Veteran has had left lower extremity radiculopathy approximating mild incomplete paralysis of the sciatic nerve. 5. Since September 30, 2020, the Veteran's sensory impairment right lower extremity most nearly approximates moderate incomplete paralysis of the sciatic nerve. 6. Since September 30, 2020, the Veteran's sensory impairment left lower extremity most nearly approximates moderately severe incomplete paralysis of the sciatic nerve. 7. For the entire period on appeal, the Veteran's pilonidal cyst required constant or near-constant systemic therapy of antibiotics that are like or similar to immunosuppressive drugs; however, such did not result in disfigurement other than hyperpigmentation, symptomatic scarring, scarring of a size so as to warrant a separate compensable rating, or any additional disabling effects. CONCLUSIONS OF LAW 1. The criteria for an initial rating of 20 percent, prior to August 18, 2021, for lumbar spine disability, is met. 38 U.S.C. §§ 1155, 5107; 38 C.F.R. §§ 4.1, 4.3, 4.7, 4.71a, Diagnostic Codes 5237, 5242. 2. The criteria for a rating in excess of 20 percent, on and after August 18, 2021, for lumbar spine disability have not been met. 38 U.S.C. §§ 1155, 5107; 38 C.F.R. §§ 4.1, 4.3, 4.7, 4.71a, Diagnostic Codes 5237, 5242. 3. The criteria for a separate 10 percent rating but no higher for right lower extremity lumbar radiculopathy beginning on November 19, 2019, have been met. 38 U.S.C. § 1155; 38 C.F.R. §§ 4.71a, 4.124a, Diagnostic Code 8520. 4. The criteria for a separate 10 percent rating but no higher for left lower extremity lumbar radiculopathy beginning on November 19, 2019, have been met. 38 U.S.C. § 1155; 38 C.F.R. §§ 4.71a, 4.124a, Diagnostic Code 8520. 5. Beginning September 30, 2020, the criteria for an increased rating of 20 percent, but no higher, for the right lower extremity radiculopathy have been met. 38 U.S.C. §§ 1155, 5103, 5107; 38 C.F.R. §§ 3.159, 3.400, 4.1-4.7, 4.124a, Diagnostic Code 8520. 6. Beginning September 30, 2020, the criteria for an increased rating of 40 percent, but no higher, for the left lower extremity radiculopathy have been met. 38 U.S.C. §§ 1155, 5103, 5107; 38 C.F.R. §§ 3.159, 3.400, 4.1-4.7, 4.124a, Diagnostic Code 8520. 7. The criteria for an initial rating of 60 percent, but no higher, for pilonidal cyst have been met. 38 U.S.C. §§ 1155, 5107; 38 C.F.R. §§ 4.1, 4.2, 4.3, 4.7, 4.118, Diagnostic Code 7806. REASONS AND BASES FOR FINDINGS AND CONCLUSIONS The Veteran served on active duty from June 1998 to February 2006. In January 2021, the Veteran testified at a video conference hearing (hearing) before the undersigned Veterans Law Judge. A transcript of the hearing is associated with the claims file. This matter was previously remanded by the Board of Veterans' Appeals (Board) in May 2021 for additional development. It now returns for further appellate review. While the claims were on remand, the Regional Office (RO) granted increased ratings for the Veteran's lumbar spine and pilonidal cyst disabilities effective August 18, 2021. See August 2021 Rating Decision. The RO also granted service connection for bilateral lower extremity radiculopathy. Id. The Board notes assigned ratings did not cover the entire period on appeal or represent maximum benefits available. See AB v. Brown, 6 Vet. App. 35, 38 (1993) (The Veteran is presumed to seek the maximum available benefit for a disability.) As such, the Veteran's claims remain on appeal. The Board has separately captioned above the additional issues. 1. Entitlement to an initial rating of 20 percent for lumbar degenerative arthritis with lumbosacral strain The Veteran disagreed with the initial 10 percent rating assigned for her service-connected lumbar spine disability. See July 2015 Notice of Disagreement (NOD). Legal Criteria Prior to August 18, 2021, the Veteran was assigned a 10 percent rating for the lumbar spine, pursuant to diagnostic code (DC) 5237 for lumbosacral strain. The Veteran disagreed with the initial rating assigned for this disability on September 30, 2014. See July 2015 NOD. Therefore, the relevant temporal focus of this claim is from October 23, 2013, the date of the initial claim for service connection. DC 5237 directs VA to rate the Veteran under either the General Rating Formula for Diseases and Injuries of the Spine or the Formula for Rating Intervertebral Disc Syndrome (IVDS) Based on Incapacitating Episodes. 38 C.F.R. § 4.71a, DCs 5237-5243 (2020). Under 38 C.F.R. § 4.71a, DCs 5235 to 5243, spine disorders are to be rated under the General Rating Formula for Diseases and Injuries of the Spine on the basis of limitation of motion. Under these diagnostic codes, a 10 percent rating is assigned when rating forward flexion of the thoracolumbar spine is greater than 60 degrees but not greater than 85 degrees; or, combined range of motion of the thoracolumbar spine greater than 120 degrees but not greater than 235 degrees; or, muscle spasm, guarding, or localized tenderness not resulting in abnormal gait or abnormal spinal contour; or, vertebral body fracture with loss of 50 percent or more of the height. A 20 percent rating is assigned when forward flexion of the thoracolumbar spine is greater than 30 degrees, but not greater than 60 degrees; when the combined range of motion of the thoracolumbar spine is not greater than 120 degrees; or when there is muscle spasm or guarding severe enough to result in an abnormal gait or abnormal spinal contour such as scoliosis, reversed lordosis, or abnormal kyphosis. A 40 percent rating is assigned when forward flexion of the thoracolumbar spine is 30 degrees or less, or there is favorable ankylosis of the entire thoracolumbar spine. A 50 percent rating is assigned when there is unfavorable ankylosis of the thoracolumbar spine only. Finally, a 100 percent rating is assigned when there is unfavorable ankylosis of the entire spine. As described above, the higher rating for 50 percent requires unfavorable ankylosis of the entire thoracolumbar spine. 38 C.F.R. § 4.71, Diagnostic Code 5242. The Court, citing Dorland's Illustrated Medical Dictionary (28th ed. 1994), has recognized that ankylosis is defined as "immobility and consolidation of a joint due to disease, injury or surgical procedure," for VA compensation purposes. See Colayong v. West, 12 Vet. App. 524, 528 (1999). The General Rating Formula for Diseases and Injuries of the Spine, provides further guidance in rating diseases or injuries of the spine. In pertinent part, Note (1) provides that any associated objective neurologic abnormalities, including, but not limited to, bowel or bladder impairment, should be rated separately under an appropriate diagnostic code. Note (2) provides that, for VA compensation purposes, normal forward flexion of the thoracolumbar spine is zero to 90 degrees, extension is zero to 30 degrees, left and right lateral flexion are zero to 30 degrees, and left and right lateral rotation are zero to 30 degrees. The combined range of motion refers to the sum of the range of forward flexion, extension, left and right lateral flexion, and left and right rotation. The normal combined range of motion of the thoracolumbar spine is 240 degrees. The normal ranges of motion for each component of spinal motion provided in this note are the maximum that can be used for calculation of the combined range of motion. See also Plate V, 38 C.F.R. § 4.71a. Effective February 7, 2021, VA's Schedule, 38 C.F.R. Part 4, was amended with regard to rating musculoskeletal disorders. Fed. Reg. 76453 (November 30, 2020) (codified at 38C.F.R. §4.71a). When a law or regulation changes during the course of a claim or an appeal, the version more favorable to the veteran will apply, to the extent permitted by any stated effective date in the amendment in question. VAOPGCPREC 3-2000; Kuzma v. Principi, 341 F.3d 1327 (Fed. Cir. 2003). The revised musculoskeletal regulations do not provide for retroactive application; thus, the amendments may be applied as of, but not prior to, February 7, 2021. Hence, VA has made clear that its intent is that the claims pending prior to the effective date will be considered under both old and new rating criteria, and whatever criteria is more favorable to the Veteran will be applied. For applications filed on or after the effective date, only the new criteria will be applied. As the Veteran's claim was pending prior to February 7, 2021, the Board will consider entitlement under the prior regulations as well as the updated regulations from February 7, 2021, forward, applying the most favorable criteria for the Veteran. The changes effective February 7, 2021, under 38 C.F.R. § 4.71a, DC 5242 and 5243 were not to the rating schedule itself but added instruction to classify disabilities associated with IVDS under DC 5243 and all other intervertebral disc disabilities under 5242. As such, DC 5242 now reflects "Degenerative arthritis, degenerative disc disease other than intervertebral disc syndrome (also, see either DC 5003 or 5010);" DC 5243 now reflects "Intervertebral disc syndrome: Assign this diagnostic code only when there is disc herniation with compression and/or irritation of the adjacent nerve route; assign diagnostic code 5242 for all other disc diagnoses." As such, the changes do not impact the general rating formula and evaluation of the disability under the pre-and post-February 7, 2021, regulations is not required. Factual Background As noted above, the Veteran filed a claim for service connection for a lumbar spine disability in October 2013. See October 2013 VA Form 21-526EZ. In January 214, a VA physical therapist found the Veteran with spasm of back muscles due to a long history of low back pain. See January 2014 VA Physical Therapy Consult, in CAPRI received March 2014. The physical therapist notes that the Veteran had normal lumbar range of motion (ROM), but no specific findings were reported. The Veteran attended a VA examination in December 2014. See December 2014 VA Back (Thoracolumbar Spine) Conditions DBQ. The examiner diagnoses the Veteran with lumbosacral strain. The Veteran rated her back pain as a 4 or 5 out on the scale of 1 to 10. Id. The Veteran reports increased pain with repetitive bending, sudden turning, and sitting for more than 45 minutes at work. She also experiences early morning stiffness and pain. She denies any flare-ups but reported that her pain increased from 4 to 5 to an 8 out of 10 with repetitive use over time. On ROM examination, the Veteran demonstrates forward flexion to 85 degrees, extension to 30 degrees, bilateral (left and right) lateral flexion to 30 degrees, bilateral (left and right) lateral rotation to 30 degrees. See December 2014 VA Back Conditions DBQ. The examiner notes that abnormal ROM did not contribute to functional loss. There was no evidence of pian on weight-bearing. Id. The examiner notes the Veteran was able to perform observed repetitive use testing, and her ROM on repetitive use remain unchanged. The Veteran was not examined on repeated use over time. The examiner states the Veteran's statements regarding functional loss with repeated use over time were consistent with the examination. Id. The Veteran's spine was tender on palpitation, and the Veteran had muscle spasms of the lumbar spine without resulting in abnormal gait or spinal contour. The Veteran displayed normal strength and no sensory deficits. Id. The examiner notes that the Veteran had symptoms of radiculopathy including mild bilateral lower extremity numbness. However, the examiner did not assess the severity of the Veteran's radiculopathy. The Veteran did not have ankylosis of the spine or IVDS. Id. The Veteran treats her back pain with a TENS unit occasionally. The RO granted service connection for lumbar spine strain and assigned a 10 percent rating. See March 2015 Rating Decision. In March and May 2016, the Veteran complains of moderate low back pain with intermittent radiating pain to her bilateral anterior thighs. See March and May 2016 Private Treatment Records from Dr. S.O. The Veteran denies any paresthesias or weakness in March 2016. Id. In May 2016, she reports she had an acute exacerbation "job related repetitive lifting of 2000." Id. Dr. S.O. diagnoses the Veteran with low back pain and prescribed Etodolac for pain. The Veteran attended a VA examination in March 2017, to assess the current severity of her lumbar spine disability. See March 2017 VA Back Conditions DBQ. The examiner confirms the Veteran's diagnosis was lumbosacral strain without radiculopathy. The Veteran rates her current back pain as 7 out of 10 in severity. She endorses low back spasms and pain that radiates down anterior thigh above her knee twice a week. However, she denies numbness or tingling in her legs. Her current treatment includes TENS unit twice a week, Flexeril, Tramadol, and Meloxicam daily. The Veteran endorses flare-ups. However, the examiner did not record the Veteran's frequency, severity, and duration of symptoms during a flare-up. The examiner notes that the Veteran's initial ROM was normal with forward flexion to 90 degrees, extension to 30 degrees, and bilateral (left and right) lateral flexion to 30 degrees, bilateral (left and right) lateral rotation to 30 degrees. The Board observes that the March 2017 VA examination is considered inadequate for rating purposes as noted in the May 2021 Board remand. Thus, a lengthy discussion of this examination is unnecessary and is provided for context only. In November 2019, the Veteran complains of constant aching pain that radiates to her legs bilaterally. See November 2019 Core Chiropractic, Private Treatment Record. On ROM testing, the Veteran demonstrates forward flexion to 50 to 60 degrees, extension from 15 to 25 degrees, bilateral (left and right) lateral flexion to 20 to 25 degrees, right lateral rotation to degrees 25 to 30 degrees, and left lower extremity lateral ration ot 30 degrees. Id. The chiropractor diagnosis the Veteran with lumbago with sciatica, unspecified side. Id. The Veteran attended another VA examination in September 2020. See September 2020 VA Back Conditions DBQ. The examiner confirms the Veteran's current diagnosis included lumbosacral strain, lumbar degenerative arthritis, and bilateral lower extremity radiculopathy. The Veteran endorses symptoms of back pain and numbness in her legs. She also endorsed flare-ups which occur four times a week. She described her back pain during flare-ups as moderate to severe. Id. On initial ROM testing, the Veteran demonstrates forward flexion to 55 degrees, extension from 10 degrees, bilateral (left and right) lateral flexion to 10 degrees, right lateral rotation to degrees 10 degrees, and left lower extremity lateral ration to 15 degrees. The examiner notes pain on examination causes functional loss. The Veteran also demonstrates pain on weight-bearing. The ROM results remain unchanged on repetitive use testing after three reputations. Id. The Veteran tests positive on bilateral straight leg raise. The examiner indicates that the Veteran had symptoms of bilateral lower extremity radiculopathy. Id. The Veteran does not have ankylosis. The Board also observes that the September 2020 VA examination is considered inadequate for rating purposes as noted in the May 2021 Board remand. Thus, a lengthy discussion of this examination is unnecessary and is provided for context only. The Board remanded the claim in May 2021 to obtain retrospective opinions to address the deficiencies in the March 2017 and September 2020 VA examinations. Consequently, the RO obtained a VA examination and opinion in August 2021. The August 2021 VA examiner confirms the Veteran's current diagnosis were lumbar spine degenerative arthritis, lumbosacral strain, and mild bilateral sciatic radiculopathy. See August 2021 Back Conditions DBQ. The Veteran endorses flare-ups occurring three to four times a week, which last four hours and are precipitated by overuse. Id. She experiences increased dull achy pain and difficulty standing and walking for prolonged periods during a flare-up. The examiner indicates the Veteran experienced moderately severe pain during flare-ups. Id. The Veteran's active ROM testing revealed forward flexion to 90 degrees, extension to 20 degrees, bilateral (left and right) lateral flexion to 20 degrees, and bilateral (left and right) lateral to degrees. The examiner indicates passive ROM could not be tested due to lack of second examiner. Id. The examiner found evidence of pain on weight-bearing, and active motion. No evidence of pain was found on non-weight-bearing. There was no objective evidence of crepitus. The Veteran's ROM was reduced by 5 degrees on observed repetitive use in all planes. The examiner notes that the Veteran did not perform ROM testing on repeated use over time but estimated the Veteran's ROM was reduced by 10 degrees in all planes on repeated use over time. Finally, the examiner estimated the Veteran's ROM during flare ups as forward flexion to 75 degrees, extension to 5 degrees, bilateral (left and right) lateral flexion to 5 degrees, and bilateral (left and right) lateral to degrees. Id. The examiner found that the Veteran had mild bilateral lower extremity radiculopathy. Id. The Veteran does not have ankylosis or IVDS. In providing a retrospective opinion, the August 2021 VA examiner also states that the Veteran's current examination was similar to the March 2017 and September 2020 VA examination with regard to loss of ROM during flare-ups. See August 2021 VA Medical Opinion DBQ. Analysis After a review of the evidence of record, the Board finds that the evidence warrants assigning an initial rating of 20 percent for the Veteran's lumbar spine disability, and no more, throughout the appeal. In reaching this conclusion, the Board acknowledges that the March 2017 VA examination demonstrated forward flexion to 90 degrees. She also demonstrates forward flexion to 50 degrees November 2019 and at the September 2020 VA examinations. See November 2019 Core Chiropractic Treatment Record; September 2020 VA Back Conditions DBQ. However, the August 2021 VA examiner offers additional insight as to the impact of the Veteran's reported flare-ups on her range of motion. Mitchell v. Shinseki, 25 Vet. App. 32, 44 (2011); Sharp v. Shulkin, 29 Vet. App. 26, 33 (2017). See August 2021 VA Medical Opinion DBQ (stating that the Veteran's March 2017 and September 2020 VA examination with regard to loss of ROM during flare-ups were similar to August 2021 VA examination findings). The Board notes that the RO granted a 20 percent rating effective August 18, 2021, based on the August 2021 VA examination findings. The August 2021 VA examiner opinion supports a finding that the Veteran's forward flexion throughout the entire period on appeal equated forward flexion to less than 60 degrees, commensurate with the criteria for a 20 percent rating under DC 5237. Additionally, while the Board notes that at no time during this period has the Veteran's thoracolumbar spine flexion shown to be less than 50 degrees, because the earlier VA examinations were not adequate for rating purposes, and resolving all reasonable doubt in her favor, the Board finds that a 20 percent rating is warranted prior to August 18, 2021. 2. Entitlement to a rating in excess of 20 percent for lumbar degenerative arthritis Analysis Upon review, the Board concludes that the evidence does not support a rating in excess of 20 percent at any point during the appeals period. Specifically, the Veteran's forward flexion has been limited to, at most, 50 degrees. See November 2019 Core Chiropractic Treatment Record; September 2020 VA Back Conditions DBQ; August 2021 Back Conditions DBQ. The Board also notes that a Veteran may be entitled to a higher disability evaluation for a musculoskeletal disability than what is supported by mechanical application of the rating schedule where there is evidence that his or her disability causes additional functional loss, such as the inability to perform the normal working movements of the body with normal excursion, strength, speed, coordination, and endurance, including as due to pain. 38 C.F.R. § 4.40 (2020); see Lyles v. Shulkin, 29 Vet. App. 107, 117 (2017). A higher disability evaluation may also be awarded where there is a reduction of a joint's normal excursion of movement in different planes, including changes in the joint's range of movement, strength, fatigability, or coordination. 38 C.F.R. § 4.45. However, the veteran's functional loss must result in limitation of motion sufficient to satisfy the next disability rating allowable for that particular disorder to be entitled to a higher disability rating under §§ 4.40 and 4.45. See Thompson v. McDonald, 815 F.3d 781, 785-86 (Fed. Cir. 2016). Here, with respect to functional loss, the evidence shows that the Veteran's range of motion (ROM) for flexion consistently exceeded 30 degrees, which is required for the next higher 40 percent rating for the entire period on appeal. See November 2019 Core Chiropractic Treatment Record; September 2020 VA Back Conditions DBQ; August 2021 Back Conditions DBQ. Therefore, the Board finds that even when considering the functional limitations of less movement than normal as identified in 38C.F.R. §§4.40, 4.45 4.59 as well as the criteria in DeLuca v. Brown and Mitchell v Shinseki, the Veteran's functional loss did not equate to the criteria required for a 40 percent rating when considering the cumulative picture of her lumbar spine disability. 8 Vet. App. 202 (1995), 25 Vet. App. 32 (2011). Further, even considering the presence of pain and limitations during a flare-up, the Veteran's flexion was limited to at most 50 degrees, which is still in excess of the requirement for the next higher rating of 40 percent, flexion limited to 30 degrees. See Correia v. McDonald, 28 Vet. App. 158 (2016); Sharp v. Shulkin, 29 Vet. App. 26 (2017). Finally, while the Veteran has reported flare-ups, there is no indication she suffered from such restricted range of motion of the lumbar spine that it may be considered the functional equivalent of ankylosis. See Chavis v. McDonough, 34 Vet. App. 1, 10 (2021). In fact, the March 2017, September 2020, and August 2021 VA examiners all found no evidence of ankylosis or the functional equivalent of ankylosis. In addition to considering the orthopedic manifestations of a lumbar spine disability, VA regulations also require that consideration be given to any associated objective neurologic abnormalities, which are to be evaluated separately under an appropriate diagnostic code. Here, the evidence does not support a finding for separate ratings based on either bowel or bladder impairment at any point during the pendency of the appeal. In reaching the above conclusions, the Board has reviewed the Veteran's statements including her testimony before the undersigned, and with regard to the severity of her lumbar spine disability. In this regard, the Veteran is competent to report on factual matters for which she has firsthand knowledge, e.g., experiencing chronic pain in her back, or experiencing a worsening of that pain. See Washington v. Nicholson, 19 Vet. App. 362, 368 (2005). The Veteran has provided lay evidence through written statements and during her examinations conducted during the course of this appeal with respect to the presence of pain and the severity of such during her VA examinations. She is competent to provide such statements, and the Board finds that the Veteran's statements are credible. See Jandreau v. Nicholson, 492 F.3d 1372, 1376-77 (Fed. Cir. 2007). Nevertheless, the Board finds the Veteran's statements are not indicative of symptomatology that is more severe than that observed at her VA examinations and do not describe symptoms that would warrant a higher rating. As such, the Board accords greater probative weight to the objective medical findings provided by the Veteran's VA examination reports. See Guerrieri v. Brown, 4 Vet. App. 467, 470-71(1993). In sum, as the evidence does not support finding a rating in excess of 20 percent is warranted, the claim is denied. See 38 U.S.C. § 5107 (b); Gilbert v. Derwinski, 1 Vet. App. 49, 55-57 (1991). 3. Entitlement to service connection for right lower extremity radiculopathy effective November 19, 2019 4. Entitlement to service connection for left lower extremity radiculopathy effective November 19, 2019 In addition to considering the orthopedic manifestations of a lumbar spine disability, VA regulations also require that consideration be given to any associated objective neurologic abnormalities, which are to be evaluated separately under an appropriate diagnostic code. Here, the evidence supports a finding of separate ratings for radiculopathy of the right and left lower extremities. In this regard, the Board notes that the RO granted service connection for bilateral lower extremity radiculopathy effective August 18, 2021. See August 2021 Rating Decision. Here, however the Board finds that the Veteran is entitled to compensation for radiculopathy of the right and left lower extremities prior to August 2021. Specifically, the first diagnosis of bilateral radiculopathy was in November 2019, during the appeal period for her lumbar spine disability. The evidence shows she has consistently complained of radiation pain in her lower extremities. In November 2019, the Veteran reports bilateral lower extremity pain radiating from her back and the private physician assesses the Veteran with sciatica. See November 2019 Core Chiropractic Treatment Record. The Veteran is competent to report radicular pain because it observable first-hand. See Layno v. Brown, 6 Vet. App. 465 (1994). Notably, the September 2020 VA examiner also diagnoses the Veteran with bilateral lower extremity radiculopathy. See September 2020 VA Back Conditions DBQ. Therefore, resolving all reasonable doubt in the Veteran's favor, the Board finds that separate 10 percent ratings are warranted for mild radiculopathy of the right and left lower extremities under Diagnostic Code 8520 for the period beginning November 19, 2019. However, the higher 20 percent evaluation is not warranted beginning November 19, 2019, under Diagnostic Code 8520 for the bilateral lower extremity radiculopathy as the Veteran's neurological symptoms are not shown to be moderate in degree because neurologic symptoms appear to be wholly sensory, and the Veteran complained on intermittent symptoms during this period. See 38 C.F.R. § 4.124a. 5. Entitlement to a 20 percent rating for left lower extremity radiculopathy from September 30, 2020 6. Entitlement to a 40 percent rating for left lower extremity radiculopathy from September 30, 2020 In order to maximize the Veteran's benefits, the Board considered whether the Veteran was entitled to higher ratings for her bilateral lower extremity radiculopathy. Legal Criteria The Veteran's bilateral lower extremity radiculopathy has been rated under DC 8520. DC 8520, which governs disabilities of the sciatic nerve, provides for a 20 percent disability rating where there is moderate incomplete paralysis of the sciatic nerve. 38 C.F.R. § 4.124a (diseases of the peripheral nerves), DC 8520. A 40 percent disability rating is assigned where there is moderately severe incomplete paralysis. A 60 percent disability rating is appropriate where there is severe incomplete paralysis with marked muscular atrophy. A maximum schedular 80 percent disability rating is assigned where the evidence shows complete paralysis of the sciatic nerve; with symptoms where the foot dangles and drops, no active movement possible of the muscles below the knee, flexion of knee weakened or lost. 38 C.F.R. § 4.124a, DC 8520. Regulations provide that ratings for peripheral neurological disorders are to be assigned based on the relative impairment of motor function, trophic changes, or sensory disturbance. 38 C.F.R. § 4.120. Consideration is also given for loss of reflexes, pain, and muscle atrophy. See 38 C.F.R. §§ 4.123, 4.124. The term "incomplete paralysis" indicates a degree of lost or impaired function substantially less than the type picture for complete paralysis given with each nerve, whether due to varied level of the nerve lesion or to partial regeneration. When the involvement is wholly sensory, the rating is for the mild, or at most, the moderate degree. The disability ratings for the peripheral nerves are for unilateral involvement; when bilateral, the ratings combine with application of the bilateral factor. 38 C.F.R. § 4.124a, Note at "Diseases of the Peripheral Nerves." The Note to 38 C.F.R. § 4.124a establishes a maximum disability rating for conditions that are wholly sensory, as opposed to a minimum disability rating for conditions that are more than wholly sensory. See Miller v. Shulkin, 28 Vet. App. 376 (2017). Discussion The September 2020 VA examiner evaluates the Veteran's radiculopathy symptoms. See September 2020 VA Back Conditions DBQ. The examiner indicates that the Veteran had symptoms of radiculopathy related to her back condition with sciatic nerve and femoral nerve involvement. Id. The Veteran's symptoms include severe paresthesias and/or dysesthesias and numbness, and intermittent pain of the left lower extremity radiculopathy, and moderate right lower extremity paresthesias and/or dysesthesias, numbness, and intermittent pain. Id. The VA examiner concludes the severity of the Veteran's right lower extremity radiculopathy as moderate and her left lower extremity radiculopathy as severe. The Veteran did not have any muscle atrophy, and demonstrates normal muscle strength. Id. During an August 2021 VA examination for the Veteran's back disability, the VA examiner also addresses the Veteran's bilateral lower extremity radiculopathy. See August 2021 VA Back Conditions DBQ. The Veteran rates her numbness and tingling in her legs at a level 6 to 8 out of 10. Id. The examiner characterizes the nature of Veteran's bilateral lower extremity radiculopathy symptoms as mild paresthesias and/or dysesthesias, and mild numbness. Based on a review of the evidence of record, the Board finds that a 20 percent rating is warranted for radiculopathy of the right lower extremity effective September 30, 2020. See September 2020 VA Back Conditions DBQ. Specifically, the September 2020 VA examiner concludes that the Veteran's right lower extremity radiculopathy was moderate in severity. Additionally, the Veteran endorses moderate right lower extremity paresthesias and/or dysesthesias, numbness, and intermittent pain. These findings support a 20 percent effective September 30, 2020. Although the Veteran's radiculopathy was specifically found to be "mild" in degree by the VA examiner in August 2021, the Veteran's right lower extremity numbness and tingling resulted in pain which she rates as 6 to 8 out of 10. As noted previously, however, when the involvement is wholly sensory, the rating should be for the mild, or at most, the moderate degree. As such, and resolving reasonable doubt in the Veteran's favor, the Board finds that a 20 percent rating is warranted under DC 8520 for the Veteran's right lower extremity radiculopathy beginning September 30. 2020. A disability rating in excess of 20 percent, however, is not found, as the Veteran does not have moderately severe or severe incomplete paralysis or complete paralysis. Furthermore, the evidence of record, to include the VA examination reports, show no more than moderate incomplete paralysis. Upon review of the record, and giving the Veteran the benefit of the doubt, the Board finds that a 40 percent disability rating, for moderately severe incomplete paralysis is warranted for her left lower extremity radiculopathy beginning September 30, 2020. The Board notes that the September 2020 VA examination report confirms severe paresthesias and/or dysesthesias and numbness, and intermittent pain of the left lower extremity radiculopathy. See September 2020 VA Back Conditions DBQ. Id. The VA examiner rates the severity of the Veteran's left lower extremity radiculopathy as severe. However, the Veteran did not have any muscle atrophy, and demonstrates normal muscle strength. Id. Resolving reasonable doubt in the Veteran's favor, the Board notes that the findings noted in the September 2020 VA examination report support a 40 percent rating for the Veteran's right lower extremity radiculopathy from the date of the examination. However, the Board does not find a rating in excess of 40 percent is warranted, because the medical and lay evidence does not more nearly approximate the severe criteria. Specifically, the rating criteria severe incomplete paralysis under DC 8520 requires marked muscle atrophy as an element and the evidence weighs against the presence of this symptom. 38 C.F.R. § 4.124a, DC 8520. Muscle atrophy and trophic changes for left lower extremity have not been reported. Notably, the are no assertions of loss of use for right lower extremity. In reviewing Veteran's bilateral lower extremity radiculopathy, the Board has carefully reviewed and considered the Veteran's statements regarding the severity of her bilateral lower extremity radiculopathy. The Veteran is competent to report observable symptoms and her statements are credible. However, the competent medical evidence offering detailed specific specialized determinations pertinent to the rating criteria are the most probative evidence with regard to evaluating the pertinent symptoms for the disability on appeal. The lay testimony has been considered together with the probative medical evidence clinically evaluating the severity of the pertinent disability symptoms. In sum, the Board resolves reasonable doubt in the Veteran's favor and finds that Veteran's left lower extremity radiculopathy more nearly approximates moderately severe incomplete paralysis. Accordingly, the Board grants a 40 percent rating for her service-connected left lower extremity radiculopathy beginning September 30, 2020. Additionally, given the evidence of record, the Board finds that a 20 percent rating, but no higher, for radiculopathy of the left lower extremity is warranted effective September 30, 2020. To the extent that any higher level of compensation is sought, the evidence is against the claim and the claims are denied. Hence the benefit-of-the-doubt rule does not apply. Gilbert v. Derwinski, 1 Vet. App. 49(1990); 38 U.S.C. §§ 5107 (b); 38 C.F.R. §§ 4.3, 4.7. 7. Entitlement to an initial 60 percent rating for pilonidal cyst The Veteran disagreed with the assigned ratings for her pilonidal cyst, which was rated as noncompensable prior to August 18, 2021, and rated as 10 percent disabling thereafter. See July 2015 NOD. The Veteran also reports extremely painful abscesses associated with her pilonidal cysts, which reoccur approximately every three months. See Hearing Transcript. Legal Criteria The Veteran's pilonidal cyst is rated pursuant to DC 7899-7820. Hyphenated diagnostic codes are used when a rating under one diagnostic code requires use of an additional diagnostic code to identify the basis for the evaluation assigned. 38 C.F.R. § 4.27. When an unlisted disease, injury, or residual condition is encountered, requiring rating by analogy, the diagnostic code number is "built up" with the first two digits being selected from that part of the schedule most closely identifying the part, and the last two digits being "99" for an unlisted condition. Here, the Veteran's disability was rated by analogy under 7820 for infections of the skin not listed elsewhere (including bacterial, fungal, viral, treponemal and parasitic diseases). DC 7820 directs that the skin condition should be rated as disfigurement of the head, face, or neck (DC 7800), scars (DC 7801, 7802, 7803, 7804, or 7805), or dermatitis (DC 7806), depending upon the predominant disability. 38 C.F.R. § 4.118, DC 7820. Because the Veteran's pilonidal cyst is not of the head, face, or neck, the DCs for disfigurement of the head, face, or neck, and for scars are not appropriate. Prior to August 13, 2018, under DC 7806, a 10 percent evaluation is warranted for dermatitis or eczema affecting at least 5 percent, but less than 20 percent of the entire body or of the exposed areas, or requiring intermittent systemic therapy such as corticosteroids or other immunosuppressive drugs for a total duration of less than six weeks during the past 12-month period. A 30 percent evaluation is warranted for dermatitis or eczema affecting 20 percent to 40 percent of the entire body or of the exposed areas, or requiring systemic therapy such as corticosteroids or other immunosuppressive drugs for a total duration of six weeks or more, but not constantly, during the past 12-month period. A maximum 60 percent evaluation is warranted for dermatitis or eczema affecting 40 percent of the entire body or more than 40 percent of the exposed areas, or constant or near-constant systemic therapy such as corticosteroids or other immunosuppressive drugs during the past 12-month period. See 38 C.F.R. § 4.118, DC 7806. As applied in the instant matter, DC 7806 also provides that dermatitis may be rated under DCs 7800-7805, depending on the predominant disability. Such DCs provide compensable ratings for disfigurement of the head, face, or neck (DC 7800), scars that are at least six square inches (39 sq. cm) (DCs 7801, 7802), or scars that are unstable or painful (DC 7804). Additionally, DC 7805 provides that any disabling effect not considered in a rating provided under DCs 7800-04 should be evaluated under an appropriate DC. As of August 13, 2018, DC 7806 provides that dermatitis is rated under the General Rating Formula for the Skin. In this regard, such provides for a 10 percent rating where there is characteristic lesions involving at least 5 percent, but less than 20 percent, of the entire body affected; or at least 5 percent, but less than 20 percent, of exposed areas affected; or intermittent systemic therapy including, but not limited to, corticosteroids, phototherapy, retinoids, biologics, photochemotherapy, PUVA, or other immunosuppressive drugs required for a total duration of less than 6 weeks over the past 12 month period. A 30 percent rating is assigned where there are characteristic lesions involving 20 to 40 percent of the entire body or 20 to 40 percent of exposed areas affected; or systemic therapy including, but not limited to, corticosteroids, phototherapy, retinoids, biologics, photochemotherapy, PUVA, or other immunosuppressive drugs required for a total duration of 6 weeks or more, but not constantly, over the past 12 month period. A 60 percent rating is warranted where there are characteristic lesions involving more than 40 percent of the entire body or more than 40 percent of exposed areas affected; or constant or near-constant systemic therapy including, but not limited to, corticosteroids, phototherapy, retinoids, biologics, photochemotherapy, PUVA, or other immunosuppressive drugs required over the past 12 month period. Under the new criteria, a note preceding 38 C.F.R. § 4.118 provides that, for the purposes of this section, "systemic therapy is treatment that is administered through any route (orally, injection, suppository, intranasally) other than the skin, and topical therapy is treatment that is administered through the skin." With regard to the meaning of "systemic therapy" prior to the new definition of the term in the revised criteria, the Court held that "[c]ompensation is available for all systemic therapies that are like or similar to corticosteroids or other immunosuppressive drugs." Warren v. McDonald, 28 Vet. App. 194, 197-99 (2016). Further, in Johnson v. Shulkin, 862 F.3d 1351 (Fed. Cir. 2017), the Federal Circuit found that "systemic therapy" means "treatment pertaining to or affecting the body as a whole." Significantly, with regard to the effective date of the new criteria, VA indicated in the Supplementary Information to the Final Rule that its "intent is that the claims pending prior to the effective date will be considered under both old and new rating criteria, and whatever criteria is more favorable to the veteran will be applied." The Veteran's claim in this case was pending prior to the August 13, 2018, effective date of the new criteria, and therefore the Board will consider both the old and new criteria and apply the more favorable. However, the Federal Circuit's interpretation of the term "systemic therapy" in the old criteria applies throughout the entire period prior to the August 13, 2018, effective date of the new criteria. Rivers v. Roadway Express, 511 U.S. 298, 312-13 (1994) ("[j]udicial construction of a statute [or regulation] is an authoritative statement of what the statute [or regulation] meant before as well as after the decision of the case giving rise to that construction"); Jordan v. Nicholson, 401 F.3d 1296, 1298-99 (Fed. Cir. 2005) (a new interpretation of a statute retroactively affects decisions still open on direct review); Threatt v. McDonald, 28 Vet. App. 56, 63 (2016) (noting the "normal principle at this Court that judicial decisions operate retrospectively"). Factual Background The Veteran filed a claim for service connection for pilonidal cysts in October 2013. See October 2013 VA Form 21-526EZ. The Veteran disagrees with initial assigned rating. See July 2015 NOD. As such, the appeal period is from October 23, 2013, the date of the initial claim for service connection. The Veteran's November 2013 VA treatment records confirms she was assessed with infected pilonidal cyst. See November 2013 VA Primary Care Outpatient Note, in CAPRI received April 2014. The VA physician prescribed Keflex for her condition, and notes she recommends a referral for general surgery. Id. During a July 2014 VA primary care visit, the Veteran reports multiple cysts on or around her buttocks. See July 2014 VA Primary Care Note in CAPRI, received on February 2015. The VA clinician advises the Veteran to continue treating her pilonidal cysts with Doxycycline for outbreaks. Id. The December 2014 VA examiner notes that the Veteran was prescribed Keflex, an oral medication for less than 6 weeks during the past 12 months for the Veteran's pilonidal cyst. See December 2014 VA Skin Conditions DBQ. The examiner also indicates that the Veteran was prescribed Clindamycin topical medication on a constant to near constant basis during the past 12 months. Id. Upon physical examination, the VA examiner notes that the Veteran's skin condition affected at least 5 but less than 20 percent of total body area, with no exposed areas affected. Id. Private treatment records from June 2016 confirms the Veteran underwent surgery for removal of pilonidal cyst. See June 2016 Private Treatment Record. During the March 2017 VA examination, the Veteran reports she uses daily benzoyl peroxide body wash to prevent reoccurrence of pilonidal cysts. See March 2017 VA Skin Conditions DBQ. She also endorses residual pain near the surgical scar from her prior surgery in June 2, 2016. Id. The examiner finds that the Veteran's surgical scar was not painful, unstable, or have a total area equal to or greater than 39 square centimeters (cm). Id. She also indicates that the Veteran treated her skin condition with topical medications on a constant/near constant basis during the past 12 months. Id. Upon physical examination, the VA examiner notes that the Veteran's skin condition affected at least 5 but less than 20 percent of total body area, with no exposed areas affected. Id. Private treatment records from July 2017 confirm the Veteran received treatment in the emergency room for complaint of pilonidal cyst abscess. See Parkview Medical Center Record. She was prescribed dicloxacillin sodium four times a day. Id. VA treatment records confirms that the Veteran medication list included Doxycyline. See March 2021 VA Primary Care Note in CAPRI received June 2017. In January 2021, the Veteran testified at the Board hearing about her pilonidal cyst symptoms. See Hearing Transcript. Specifically, she reports that she has abscesses of her pilonidal cysts occurring every three months. She also notes despite laser surgery cysts still reoccur. She rates her pain at a 10 out of 10 during flare-ups of pilonidal cysts. Id. She indicates her cysts fill up with pus and get very painful, and must be lanced. She also states she was prescribed antibiotics for her pilonidal cysts. Id. The Board remanded the claim in May 2021, in part to ascertain the nature of the Veteran's therapy for her pilonidal cysts. The August 2021 VA examiner states the Veteran had long-standing pilonidal cysts that has been treated on a constant or near-constant basis with doxycycline, an oral antibiotic, and topical medications. See August 2021 VA Skin Conditions DBQ. The examiner opines that such treatment is affects the body as a whole i.e., systemic therapy. See August 2021 VA Medical Opinion DBQ. The August 2021 VA examiner notes that the Veteran's pilonidal cyst was been treated and drained a number of times during over the years. See August 2021 VA Skin Conditions DBQ. The Veteran's current treatment includes doxycyline and benzol peroxide and clindamycin wipes. Id. The examiner finds that the Veteran treats her condition with doxycycline, an oral medication, on a constant to near constant basis during the past 12 months. Id. She also used topical treatments including benzol peroxide and clindamycin wipes on a constant to near constant basis during the past 12 months. In a separate medical opinion, the August 2021 VA examiner opines that the doxycyline was an antibiotic that affects the body as a whole. See August 2021 VA Medical Opinion DBQ. Analysis As an initial matter, the Board notes that under the older and amended regulations, the Veteran's disability is appropriately rated pursuant to DCs 7820 and 7806. DC 7820 pertains to infections of the skin not listed elsewhere (including bacterial, fungal, viral, treponemal and parasitic diseases), to be rated as disfigurement of the head, face, or neck (DC 7800), scars (DCs 7801, 7802, 7803, 7804, or 7805), or dermatitis (DC 7806), depending upon the predominant disability. 38 C.F.R. § 4.118, DC 7820. In this case, the Board finds that the Veteran's pilonidal cyst is does not involve her face, head, or neck, and is more analogous to dermatitis or eczema which involve inflammation of the skin and symptoms such as itchiness or dryness. As such, her disability is appropriately rated under DC 7806 which is more favorable to the Veteran. Based on the foregoing, and resolving reasonable doubt in the Veteran's favor, the Board finds that the Veteran has used an oral antibiotic constituting systemic therapy on a constant or near-constant basis throughout the entirety of the appeal period. Therefore, an initial rating of 60 percent under DC 7806 is warranted. In this regard, the Board finds the August 2021 opinion highly probative as it concludes the oral antibiotic treatment used by the Veteran throughout the period on appeal is both systemic and "like or similar to" an immunosuppressive drug. See Warren v. McDonald, 28 Vet. App. 194, 197-99 (2016); Johnson v. Shulkin, 862 F.3d 1351 (Fed. Cir. 2017). Therefore, the Veteran warrants the highest rating under DC 7806 of 60 percent under both the old and new versions of DC 7806. The Board has also considered the applicability of other potential DCs referable to the evaluation of skin disabilities. However, as the evidence of record fails to demonstrate that the Veteran's pilonidal cyst caused disfigurement other than hyperpigmentation, symptomatic scarring, scarring of a size so as to warrant a compensable rating, or additional disabling effects, she is not entitled to a higher or separate rating under DCs 7800-7805. The Board has considered whether staged ratings under Fenderson, supra, are appropriate for the Veteran's service-connected pilonidal cyst; however, the Board finds that her symptomatology has been stable during the period on appeal. Therefore, assigning staged ratings for such disability is not warranted. Further, neither the Veteran nor her representatives have raised any other issues, nor have any other issues been reasonably raised by the record, in regard to the claim adjudicated herein. See Doucette v. Shulkin, 28 Vet. App. 366 (2017) (confirming that the Board is not required to address issues unless they are specifically raised by the claimant or reasonably raised by the evidence of record). Therefore, based on the foregoing, the Board finds that an initial rating of 60 percent, but no higher, for the Veteran's pilonidal cyst is warranted. This represents the highest rating available under DC 7806. In reaching such decision, the Board has considered the applicability of the benefit of the doubt doctrine. However, insofar as the Board has denied higher or separate ratings, the evidence is against such aspects of the Veteran's claim, and the benefit of the doubt doctrine is not applicable. 38 U.S.C. § 5107; 38 C.F.R. §§ 4.3, 4.7. YVETTE R. WHITE Veterans Law Judge Board of Veterans' Appeals Attorney for the Board G. Lilly, Counsel The Board's decision in this case is binding only with respect to the instant matter decided. This decision is not precedential and does not establish VA policies or interpretations of general applicability. 38 C.F.R. § 20.1303.